Revumenib Citrate

CHEMBL6068395 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

841.0 g/mol

LogP

—

Phase

4

Revumenib citrate is the citrate salt form of revumenib, a menin inhibitor that disrupts the menin-KMT2A interaction to restore normal differentiation in KMT2A-translocated acute leukemia. See revumenib for complete pharmacological details.

Molekularmasse

841,0000 g/mol

TPSA

249,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.O.O=C(O)CC(O)(CC(=O)O)C(=O)O

InChI

InChI=1S/C32H47FN6O4S.C6H8O7.H2O/c1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2;7-3(8)1-6(13,5(11)12)2-4(9)10;/h9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);1H2/t24-,26-;;

Molecular Formula

C38H57FN6O12S

HBD / HBA

6 / 18

Rotierbare Bindungen

16

Schwere Atome

58

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Revumenib citrate is the citrate salt form of revumenib, a menin inhibitor that disrupts the menin-KMT2A interaction to restore normal differentiation in KMT2A-translocated acute leukemia. See revumenib for complete pharmacological details.

Yes, Revumenib Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068395. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 169490859. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Revumenib Citrate auf PillFYI

Struktur

Schnelldaten

Formel: C38H57FN6O12S

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.